Corinne Savill
Corporate Officer/Principal en CULLINAN THERAPEUTICS, INC. .
Fortuna: 4 M $ al 30/04/2024
Cargos activos de Corinne Savill
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2017 | - |
Historial de carrera de Corinne Savill
Antiguos cargos conocidos de Corinne Savill.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CANTARGIA AB | Director/Miembro de la Junta | 01/01/2018 | 21/05/2018 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/08/2002 | 01/02/2017 |
| Imutran Ltd. | Director Ejecutivo | 01/01/1997 | 01/01/2001 |
| Director Técnico/Científico/I+D | 01/01/1995 | 01/01/1997 | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - | - |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/02/2017 | - |
Formación de Corinne Savill.
| The University of Manchester | Undergraduate Degree |
| Middlesex School | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 3 |
| Suiza | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CANTARGIA AB | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
| Imutran Ltd. |
- Bolsa de valores
- Insiders
- Corinne Savill
- Experiencia
